Financial Performance

National Peroxide Limited reported a significant turnaround in FY26 with net profit of ₹582.42 lakhs (₹5.82 crore) compared to a loss of ₹224.64 lakhs (₹2.24 crore) in FY25. Total income increased by 1.48% to ₹29,568.37 lakhs (₹295.68 crore). EBITDA improved to ₹30.21 lakhs from ₹19.70 lakhs in the previous year. Basic EPS stood at ₹10.13 compared to (₹3.91) in FY25. Cash and cash equivalents increased to ₹1,880.17 lakhs as of March 31, 2026.

Dividend Declaration

The Board recommended a Final Dividend of ₹7.00 per equity share (70%) for FY 2025-26, subject to shareholder approval at the AGM. This would result in a cash outflow of ₹402.29 lakhs, representing 69.07% of net profit. The record date is set for Tuesday, September 22, 2026.

Financial Restatement

The company disclosed restated financial statements due to an incorrect configuration in the ERP system for natural gas invoices. This resulted in raw material costs being understated by ₹694.63 lakhs and trade creditors being understated by the same amount. The revised financials were approved by the Board on August 12, 2026.

AGM Details and Voting Procedures

The 6th Annual General Meeting is scheduled for Tuesday, September 29, 2026 at 11:00 AM IST via Video Conferencing/Other Audio-Visual Means. Key agenda items include adoption of financial statements, dividend declaration, director reappointments, and auditor appointments.

Shareholders can vote remotely through the NSDL e-Voting system before the AGM or during the meeting. Mr. Nilesh Shah was appointed as Scrutiniser with alternatives Mr. Mahesh Darji and Mrs. Hetal Shah. Results will be placed on the company website and NSDL website.

Management Changes and Appointments

CFO Changes: Mr. Pravin Shetty resigned (Sep 19, 2025), Mr. Amit Goriwale served as Interim CFO (Dec 18, 2025 to May 31, 2026), and Mr. Chirag Kothari was appointed CFO (Jun 1, 2026).

Company Secretary: Mr. Amish Shah resigned (Dec 12, 2025) and Mr. Akshay Satasiya was appointed (Mar 9, 2026).

Employee strength reduced from 128 to 124 as of March 31, 2026.

Auditor Appointments

Statutory Auditors: Reappointment of M/s. Kalyaniwalla & Mistry LLP for a second term of 5 years at remuneration of ₹50 lakh for FY2026-27.

Cost Auditors: Ratification of remuneration of ₹5,00,000 plus taxes for M/s. D.C. Dave & Co. for FY2026-27 cost audit.

Director Reappointment

Mr. Ness N. Wadia (DIN: 00036049), Chairman and Non-Executive Non-Independent Director, retires by rotation and seeks reappointment. He holds 4,600 equity shares and attended all 5 board meetings during FY2025-26.

Operational and Market Position

The company maintains India's largest hydrogen peroxide manufacturing capacity of 150,000 MTPA. It introduced PV Grade Hydrogen Peroxide for solar and semiconductor applications. Export revenue accounted for ₹6,615.75 lakhs (22.96% of total revenue).

Regulatory and Compliance Matters

India Ratings revised bank loan facilities from 'IND A' to 'IND A-' with Negative Outlook. As of March 31, 2026, 27,288 equity shares were lying with Investor Education and Protection Fund Authority (IEPFA). All related party transactions were at arm's length and in ordinary course of business.

Shareholding and Corporate Structure

Promoter & Promoter Group holds 70.76%, Public holds 24.94%, and Foreign Promoter holds 21.66%. 99.999% of shares are held in dematerialized form. CSR expenditure was ₹38.94 lakhs (2% of average net profit).

Financial Impact

The dividend declaration, if approved, will result in cash outflow of ₹402.29 lakhs. The restatement corrected material misstatement in raw material costs and trade payables. No material impact on going concern status.